Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Watch Best of BIO
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Addressing Climate Change
    Strengthening the Bioeconomy
    Growing Trust in Innovation
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    Learn More >
  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO International Convention

    June 5-8, 2023 | Boston, MA
    Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership

    Learn more
    Teal Box Mega Nav
    BIO Partnering at JPM Week

    January 9-12, 2023 | San Francisco, CA

    Teal Box Mega Nav
    BIO CEO & Investor Conference

    February 6-9, 2023 | New York, NY

    Teal Box Mega Nav
    BIO-Europe Spring

    March 20-22, 2023, Basel Switzerland
     

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • BIO Media
    BIO Media

    Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.

    I am BIO Podcast
    Good Day BIO Newsletter
    I am BIO Video
    Join Today
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
156 Results Found

BTN-MTC_Patient-Pharmacy.png
Brand Name Drug Prices Fell in 2021 -- Again.
It’s a new calendar year – yet the tired drug pricing control policies of 2021 continue to float around Capitol Hill. Proponents of price controls justify their actions by claiming drug prices are “skyrocketing” and hurting Americans. That’s not surprising; For years drug prices have been a…

AMR
Antimicrobial Resistance: The Silent Pandemic
We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how the dwindling supply of new antibiotics is fueling this silent pandemic, and why…

How Drug Price Controls End Up Hurting Patients
How Drug Price Controls End Up Hurting Patients
They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress—could have unintended consequences for the small biotechs that are the engine of…

drugs
What’s Driving U.S. Health Spending? Not Prescription Medicines.
It’s no secret that the United States spends more on health care than other nations. In response to this problem, policymakers in Washington – including President Trump and Speaker Nancy Pelosi – want to impose foreign price setting schemes on prescription medicines that America’s patients rely on…

fight-covid-19-bio.png
New Drug Pricing Executive Order is “Reckless” And “Dumbfounding”
In case you missed it, the Trump administration is moving forward with a plan to import into the United States dangerous government price setting for innovative cures and treatments. In a nutshell, the move will harm the scientists and researchers working around the clock to eradicate Covid-19,…

Jeremy Levin
Challenges and Opportunities in the Biotech Industry in 2020
The 22nd annual BIO CEO & Investor Forum kicked off today with a Welcome and Update on BIO's 2020 Initiatives on Behalf of the Industry given by Jeremy Levin, CEO of Ovid Therapeutics Chair of the Board of Directors of BIO. The industry was established in 1970’s during an era of bipartisan…

BTN Blog Top Card Health
Is ICER Changing the Rules to Reach It’s Desired Outcome?
Jennifer Bright with the Innovation and Value Initiative recently wrote for Morning Consult that the U.S. is “engaged in the challenging but important conversation about how to assess the value of pharmaceuticals.”  It’s a conversation that should be transparent and open to everyone,…

BTN Blog Top Card Health
GAO Report Exposes New Weaknesses in 340B Drug Discount Program
The 340B Drug Discount Program is in the spotlight with the release of a new report from the Government Accountability Office (GAO) calling attention to oversight of the program designed to help vulnerable patients gain access to affordable prescription drugs. As the findings show, the program,…

USMCA
3 Key Points on Biologics & USMCA
This week, Congress is expected to consider a USMCA trade agreement that does NOT include stronger IP protections for American innovators who develop biologic medicines. While the removal of these provisions is being hailed as a defeat for Big Pharma, here are three key points to keep in mind as…

Patient at Pharmacy
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note: “The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but argued that the White House is working to bring…

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Impact Ag & Environment Conference
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO DOUBLE HELIX SPONSORS
Sanofi logo
Amgen logo
Bristol Myers Squibb
Genentech logo
Merck_logo_2022
BIO HELIX SPONSORS
Pfizer Inc Logo
Eli Lilly and Company
AbbVie Logo
Johnson and Johnson
Travere logo
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO